![Akihiro Furuta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Akihiro Furuta
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AskAt, Inc.
![]() AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - |
Karriereverlauf von Akihiro Furuta
Ehemalige bekannte Positionen von Akihiro Furuta
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RAQUALIA PHARMA INC. | Direktor/Vorstandsmitglied | 01.07.2008 | - |
Geschäftsführer | 08.06.2012 | 01.08.2014 | |
Technik-/Wissenschafts-/F&E-Leiter | 14.07.2011 | 08.06.2012 | |
Personalreferent | 08.06.2012 | 01.08.2014 | |
Corporate Officer/Principal | 01.08.2014 | - |
Ausbildung von Akihiro Furuta
Nagoya University | Undergraduate Degree |
Oberlin College | Undergraduate Degree |
Statistik
International
Japan | 4 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 2 |
Undergraduate Degree | 2 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RAQUALIA PHARMA INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
AskAt, Inc.
![]() AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Börse
- Insiders
- Akihiro Furuta
- Erfahrung